Patents by Inventor Ananthapadmanabhan Sivaramakrishnan

Ananthapadmanabhan Sivaramakrishnan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8309599
    Abstract: The present invention provides novel analogs of FR901464, as well as an improved methodology for preparing FR901464 and its analogs. These compounds display an anti-cancer activity and are candidates for therapies against a number of disease states associated with dysfunctional RNA splicing.
    Type: Grant
    Filed: September 15, 2010
    Date of Patent: November 13, 2012
    Assignee: University of Pittsburgh-Of The Commonwealth System of Higher Education
    Inventors: Kazunori Koide, Brian J. Albert, Ananthapadmanabhan Sivaramakrishnan
  • Publication number: 20110086909
    Abstract: The present invention provides novel analogs of FR901464, as well as an improved methodology for preparing FR901464 and its analogs. These compounds display an anti-cancer activity and are candidates for therapies against a number of disease states associated with dysfunctional RNA splicing.
    Type: Application
    Filed: September 15, 2010
    Publication date: April 14, 2011
    Inventors: Kazunori KOIDE, Brian J. Albert, Ananthapadmanabhan Sivaramakrishnan
  • Patent number: 7825267
    Abstract: The present invention provides novel analogs of FR901464, as well as an improved methodology for preparing FR901464 and its analogs. These compounds display an anti-cancer activity and are candidates for therapies against a number of disease states associated with dysfunctional RNA splicing.
    Type: Grant
    Filed: September 8, 2007
    Date of Patent: November 2, 2010
    Assignee: University of Pittsburgh-of the Commonwealth System of Higher Education
    Inventors: Kazunori Koide, Brian J. Albert, Ananthapadmanabhan Sivaramakrishnan
  • Publication number: 20080096879
    Abstract: The present invention provides novel analogs of FR901464, as well as an improved methodology for preparing FR901464 and its analogs. These compounds display an anti-cancer activity and are candidates for therapies against a number of disease states associated with dysfunctional RNA splicing.
    Type: Application
    Filed: September 8, 2007
    Publication date: April 24, 2008
    Inventors: Kazunori KOIDE, Brian Albert, Ananthapadmanabhan Sivaramakrishnan